Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Viridian Therapeutics Inc shares valued at $9,999,990 were purchased by Fairmount Funds Management LLC on Jan 22 ’24. At $21.00 per share, Fairmount Funds Management LLC acquired 476,190 shares. The insider’s holdings grew to 1,839,954 shares worth approximately $27.89 million following the completion of this transaction.
Also, Meisner Lara sold 27 shares, netting a total of over 765 in proceeds. Following the sale of shares at $28.35 each, the insider now holds 29,971 shares.
Before that, Meisner Lara had sold 2,269 shares from its account. In a trade valued at $63,577, the Chief Legal Officer traded Viridian Therapeutics Inc shares for $28.02 each. Upon closing the transaction, the insider’s holdings decreased to 2,269 shares, worth approximately $0.45 million.
Analysts at BTIG Research started covering the stock with ‘”a Buy”‘ outlook in a report released in mid June. As of May 30, 2023, RBC Capital Mkts has initiated its “an Outperform” rating for VRDN. Earlier on April 17, 2023, Wells Fargo initiated its rating. Their recommendation was “an Overweight” for VRDN stock.
Analyzing VRDN Stock Performance
During the last five days, there has been a drop of approximately -6.48%. Over the course of the year, Viridian Therapeutics Inc shares have dropped approximately -30.39%. Shares of the company reached a 52-week high of $24.18 on 01/09/24 and a 52-week low of $14.85 on 04/17/24. A 50-day SMA is recorded $17.78, while a 200-day SMA reached $17.90. Nevertheless, trading volume fell to 0.58 million shares from 0.68 million shares the previous day.
Support And Resistance Levels for Viridian Therapeutics Inc (VRDN)
According to the 24-hour chart, there is a support level at 14.81, which, if violated, would cause prices to drop to 14.46. In the upper region, resistance lies at 15.63. The next price resistance is at 16.10. RSI (Relative Strength Index) is 33.14 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.02, which suggests the price will decrease in the coming days. Percent R is at 89.08%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
